Search research articles
Contact Us
Filters
Showing results (21-30 of 116) with videos related to
Page
of 12
Sort By:
Oncoimmunology
|
November 18, 2016
Promoter methylation of the immune checkpoint receptor <i>PD-1</i> (<i>PDCD1</i>) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Diane Goltz, Heidrun Gevensleben, Jörn Dietrich, et al.
Clinical Epigenetics
|
December 22, 2021
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors
Yilin Bao, Jennis Gabrielpillai, Jörn Dietrich, et al.
Cancers
|
February 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
Thomas Büttner, Dimo Dietrich, Romina Zarbl, et al.
Clinical Epigenetics
|
December 8, 2017
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
Luka de Vos, Heidrun Gevensleben, Andreas Schröck, et al.
Ebiomedicine
|
February 4, 2018
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
Lea Kristin Röver, Heidrun Gevensleben, Jörn Dietrich, et al.
Plos One
|
October 25, 2013
Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition
Dimo Dietrich, Barbara Uhl, Verena Sailer, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
January 21, 2009
Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues
Dimo Dietrich, Ralf Lesche, Reimo Tetzner, et al.
Critical Reviews in Clinical Laboratory Sciences
|
June 1, 2014
Nucleic acid-based tissue biomarkers of urologic malignancies
Dimo Dietrich, Sebastian Meller, Barbara Uhl, et al.
Oncotarget
|
November 12, 2016
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Heidrun Gevensleben, Emily Eva Holmes, Diane Goltz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 20, 2021
Regulation of Endothelial Nitric Oxide Synthase in the Reticular Lamina of the Organ of Corti by a Nitric Oxide Donor
Ulf-Rüdiger Heinrich, Regina Meuser, Benjamin Philipp Ernst, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 116) with videos related to
Sort By:
Page
of 12
Oncoimmunology
|
November 18, 2016
Promoter methylation of the immune checkpoint receptor <i>PD-1</i> (<i>PDCD1</i>) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Diane Goltz, Heidrun Gevensleben, Jörn Dietrich, et al.
Clinical Epigenetics
|
December 22, 2021
Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors
Yilin Bao, Jennis Gabrielpillai, Jörn Dietrich, et al.
Cancers
|
February 10, 2024
Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
Thomas Büttner, Dimo Dietrich, Romina Zarbl, et al.
Clinical Epigenetics
|
December 8, 2017
Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
Luka de Vos, Heidrun Gevensleben, Andreas Schröck, et al.
Ebiomedicine
|
February 4, 2018
PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations
Lea Kristin Röver, Heidrun Gevensleben, Jörn Dietrich, et al.
Plos One
|
October 25, 2013
Improved PCR performance using template DNA from formalin-fixed and paraffin-embedded tissues by overcoming PCR inhibition
Dimo Dietrich, Barbara Uhl, Verena Sailer, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
January 21, 2009
Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues
Dimo Dietrich, Ralf Lesche, Reimo Tetzner, et al.
Critical Reviews in Clinical Laboratory Sciences
|
June 1, 2014
Nucleic acid-based tissue biomarkers of urologic malignancies
Dimo Dietrich, Sebastian Meller, Barbara Uhl, et al.
Oncotarget
|
November 12, 2016
PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy
Heidrun Gevensleben, Emily Eva Holmes, Diane Goltz, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
|
October 20, 2021
Regulation of Endothelial Nitric Oxide Synthase in the Reticular Lamina of the Organ of Corti by a Nitric Oxide Donor
Ulf-Rüdiger Heinrich, Regina Meuser, Benjamin Philipp Ernst, et al.
Page
of 12